Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul-Sep;62(3):222-227.

Macular pigment density changes in central serous chorioretinopathy

Affiliations

Macular pigment density changes in central serous chorioretinopathy

Ruxandra Tudosescu et al. Rom J Ophthalmol. 2018 Jul-Sep.

Abstract

Aim: To present a series of 2 cases of central serous chorioretinopathy and the changes in the macular pigment optical density during the evolution of the disease. Material and methods: A 32-year-old patient presented himself for blurred vision on his LE. The SD OCT imaging revealed serous macular detachment of the neurosensory retina on the LE. The MPOD results were 0.72 on RE and 0.91 on LE. After treatment and resorption of the subretinal fluid, the MPOD values were 0.72 on the RE and 0.82 on the LE. The second patient was a 36-year-old male with metamorphopsia on LE and serous macular detachment on this eye. The MPOD results were 0.43 on RE and 0.58 on the LE and, after treatment, they were 0.38 on the RE and 0.43 on the LE. Conclusions: Central serous chorioretinopathy is a disease of unknown pathophysiology in which we observed a higher MPOD on the eye with CSC than on the fellow eye and a decrease in the MPOD value after the resorption of the subretinal fluid. Abbreviations: L = lutein, Z = zeaxantin, MZ = mezozeaxantin, AMD = age related macular degeneration, MPOD = macular pigment optical density, MP = macular pigment, HFP = Heterochromatic Flicker Photometry, CSC = central serous chorioretinopathy, RE = right eye, LE = left eye.

Keywords: central serous chorioretinopathy; macular pigment optical density.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Left eye – serous macular detachment (case 1)
Fig. 2,3
Fig. 2,3
LE - Early and late phase of the angiofluorography with the expansile dot pattern (case 1)
Fig. 4
Fig. 4
OCT of the LE with serous detachment of the neuroretina (case 1)
Fig. 5
Fig. 5
MPOD measurement report before treatment (case 1)
Fig. 6
Fig. 6
MPOD measurement after treatment and with no subretinal fluid (case1)
Fig. 7
Fig. 7
SD OCT of the LE after treatment (case 1)
Fig. 8
Fig. 8
SD OCT of the LE with neurosensory detachment of the retina (case 2)
Fig. 9
Fig. 9
SD OCT of the left eye after resorption of the subretinal fluid (case 2)
Fig. 10
Fig. 10
MPOD measurement after treatment and no subretinal fluid (case 2)

Similar articles

Cited by

References

    1. Ophthalmology AAO . Fundamentals and Principals of Ophthalmology - Retina and Vitreous. San Francisco, CA: 2011.
    1. Alejandra Daruicha AM, Dirania A, Bousquet E, Zhao M, Farmand N, Jaisser F, Behar-Cohen F. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. 2015;(48):82–118. - PubMed
    1. Yanoff D. Ophthalmology Part 6 – Retina and vitreous, Section 3 – Anciliary tests, Chapter 6.8 - Fluorescein Angiography, Indocyanine Green Angiography, and Optical Coherence Tomography. 3rd ed. Mosby; 2008.
    1. Bouzas PKEA, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;(47):431–448. - PubMed
    1. Estera Igras JL, Ratzlaff M, O’Caoimh R, O’Brien C. Evidence of lower macular pigment optical density in chronic open angle glaucoma. Br J Ophthalmol. 2013;(97):994–998. - PubMed

LinkOut - more resources